A Qualitative Investigation of the Experience of Taking Xanomeline and Trospium Chloride for Schizophrenia, Part 1: Perceived Impact on Symptoms
- DOI
- 10.1093/schizbullopen/sgag002
- Published
- 2026
- Container
- Schizophrenia Bulletin Open
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/schizbullopen/sgag002,
title = {A Qualitative Investigation of the Experience of Taking Xanomeline and Trospium Chloride for Schizophrenia, Part 1: Perceived Impact on Symptoms},
author = {William P Horan and Cory Saucier and Peter J Weiden and Amy Claxton and Stephen R Marder and April M Foster and Colin Sauder and Kaitlin LaGasse and Sloan Rucker and Kristi Jackson and Tej Patel and John G Sonnenberg and Inder Kaul},
year = {2026},
journal = {Schizophrenia Bulletin Open},
doi = {10.1093/schizbullopen/sgag002},
url = {https://doi.org/10.1093/schizbullopen/sgag002}
}RIS
TY - JOUR TI - A Qualitative Investigation of the Experience of Taking Xanomeline and Trospium Chloride for Schizophrenia, Part 1: Perceived Impact on Symptoms AU - William P Horan AU - Cory Saucier AU - Peter J Weiden AU - Amy Claxton AU - Stephen R Marder AU - April M Foster AU - Colin Sauder AU - Kaitlin LaGasse AU - Sloan Rucker AU - Kristi Jackson AU - Tej Patel AU - John G Sonnenberg AU - Inder Kaul PY - 2026 JO - Schizophrenia Bulletin Open DO - 10.1093/schizbullopen/sgag002 UR - https://doi.org/10.1093/schizbullopen/sgag002 ER -
APA
Horan, W. P., Saucier, C., Weiden, P. J., Claxton, A., Marder, S. R., Foster, A. M., Sauder, C., LaGasse, K., Rucker, S., Jackson, K., Patel, T., Sonnenberg, J. G., & Kaul, I. (2026). A Qualitative Investigation of the Experience of Taking Xanomeline and Trospium Chloride for Schizophrenia, Part 1: Perceived Impact on Symptoms. Schizophrenia Bulletin Open. https://doi.org/10.1093/schizbullopen/sgag002
Source records
- crossref · retrieved 2026-09-26T09:19:22.532Z